Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

Name: Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
License: Public Domain

Noffar Bar

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

multiple myeloma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 377425
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.